Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 8, Number 2—February 2002

Research

Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada

David P. Speert*, Deborah Henry*, Peter Vandamme†, Mary Corey‡, and Eshwar Mahenthiralingam*
Author affiliations: *University of British Columbia and Children’s and Women’s Health Centre of British Columbia, Vancouver, British Columbia, Canada; †University of Ghent, Ghent, Belgium; ‡The Hospital for Sick Children, Toronto, Ontario, Canada

Main Article

Table 4

Number of cystic fibrosis patients infected with Burkholderia cepacia complex genomovar III RAPD strain type, by Canadian province

Province RAPD strain type
01 02 04 06 Other
(BCESM+)a
British Columbia 9 11 16 7 10 (5)
Alberta 2 14 16 0 0
Manitoba 0 1 1 0 1 (0)
Saskatchewan 0 0 0 0 0
Ontario 1 223 2 0 7 (5)
Quebec 5 7 1 0 2 (2)
Prince Edward Island 0 0 0 0 0
New Brunswick 0 0 2 0 1 (0)
Nova Scotia 0 2 12 0 4 (0)
Newfoundland
0
13
0
0
0
Total 17 271 50 7 25 (12)

aNumber of patients whose isolates had Burkholderia cepacia epidemic strain marker (BCESM ) in the category “other genomovar III RAPD strain types”. Strain types 01, 02, 04, and 06 all encoded BCESM. RAPD = random amplified polymorphic DNA.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO